Form 4: Castle Biosciences COO Sells Shares Under 10b5-1 Plan
Statement of Changes in Beneficial Ownership
Castle Biosciences' Chief Operating Officer, Kristen M Oelschlager, reported the sale of 12,678 shares of common stock for approximately $25.04 per share.
Summary
- Kristen M Oelschlager, Chief Operating Officer of Castle Biosciences Inc. (CSTL), sold 12,678 shares of common stock.
- The transaction occurred on October 31, 2025, at a weighted-average price of $25.04 per share, with trades ranging from $25.00 to $25.12.
- The sale was executed under a Rule 10b5-1 plan adopted by the Reporting Person on March 6, 2025.
- Following the transaction, Oelschlager directly owns 27,569 shares and indirectly owns 100,937 shares through The Fritz Shorter Trust, where she and her spouse are trustees and beneficiaries.
Sentiment
Score: 5
Explanation: Neutral. The filing reports a pre-scheduled insider sale under a 10b5-1 plan, which is a routine event and does not inherently indicate positive or negative sentiment about the company's future prospects.
Future Outlook
na
Industry Context
na
Related Party Transactions
- The Fritz Shorter Trust, where the Reporting Person and her spouse are trustees and beneficiaries, holds 100,937 shares indirectly.
Stakeholder Impact
- Shareholders may note the sale of shares by a key executive, which is a routine event when conducted under a 10b5-1 plan.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Date Rule 10b5-1 plan was adopted by the Reporting Person. |
| 10/31/2025 | Date of transaction (sale of common stock). |
| 11/04/2025 | Date the Form 4 was signed and filed. |
Keywords
Castle Biosciences, CSTL, Insider Sale, Form 4, Kristen M Oelschlager, Chief Operating Officer, Stock Transaction, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.